Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results

FHS
May 21, 2024
3:49 am

Many breast cancer survivors report cancer-related cognitive impairment following chemotherapy, although prevalence rates and severity vary.

MindBio Therapeutics Enrolls 25th Participant into Landmark Take-Home Microdosing Depression Trial | Psychedelic Invest

Vancouver, British Columbia –TheNewswire –September 23, 2024–MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6),(the “Company” or “MindBio”),a leading biopharmaceutical company in psychiatric medicine development, is delighted to report

September 25, 2024

General Catalyst’s HATCo Acquires Summa Health for $485M, Eliminates $850M in Debt

What You Should Know: – Health Assurance Transformation LLC (HATCo), a General Catalyst company has reached an agreement to acquire Summa Health, an Ohio-based health

November 8, 2024

Unveiling nature’s hunters: Dr. Skylar Johnson’s research on carnivorous pitcher plants with Absorbance 96 & One in Borneo’s rainforests

In this interview, Dr. Skylar Johnson shares her thrilling adventures and groundbreaking research on carnivorous Nepenthes pitcher plants in the lush rainforests of Borneo.

July 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.